<DOC>
	<DOCNO>NCT00090584</DOCNO>
	<brief_summary>The primary aim study test addition behavioral treatment drug therapy treatment urge incontinence increase number patient discontinue drug therapy sustain significant reduction incontinence .</brief_summary>
	<brief_title>Behavior Enhances Drug Reduction Incontinence ( BE-DRI )</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Inclusion : Female Urge predominant incontinence Incontinent &gt; 3 mo Available 8 mo followup Exclusion : Pregnancy &lt; 6 mo postpartum Hypersensitivity drug ( tolterodine ) Systemic disease affect bladder function ( e.g. , Parkinson 's disease , Multiple Sclerosis , spinal cord injury ) History extensive behavior treatment</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Urge urinary incontinence ( UUI )</keyword>
	<keyword>Drug/Behavior treatment</keyword>
</DOC>